Lana Medical Company (TADAWUL:9587)

Lana Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.84	4.53	6.35	18.75	3.3	3.52
Cash & Short-Term Investments	2.84	4.53	6.35	18.75	3.3	3.52
Cash Growth	-	-28.65%	-66.14%	467.79%	-6.03%	-
Accounts Receivable	60.1	52.53	37.38	18.91	32.77	31.21
Other Receivables	5.51	2.32	1.62	1.42	-	0.9
Receivables	65.62	54.86	39	20.33	32.77	32.11
Inventory	13.23	11.02	4.7	2.97	4.09	4.07
Prepaid Expenses	21.89	3.78	1.44	0.54	0.17	0.06
Other Current Assets	-	10.17	6.14	7.25	4.5	2.7
Total Current Assets	103.58	84.36	57.63	49.84	44.83	42.46
Property, Plant & Equipment	39.16	38.73	36.26	26.03	18.39	14.81
Long-Term Investments	8.85	9.12	8.71	-	-	-
Other Intangible Assets	0.13	0.14	0.17	0.2	-	-
Total Assets	151.72	132.35	102.77	76.07	63.22	57.28

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	23.66	4.5	5.8	1.69	1.14	1.17
Accrued Expenses	-	19.41	9.73	5.6	3.62	2.52
Short-Term Debt	19.26	-	-	-	2.04	-
Current Portion of Long-Term Debt	4.8	16.44	6.28	1.86	1.58	1.8
Current Portion of Leases	2.5	2.6	1.02	0.47	0.31	0.31
Current Income Taxes Payable	1.14	1.43	1.33	1.52	1.13	1.2
Current Unearned Revenue	7.46	3.7	2.01	3.36	-	0.54
Other Current Liabilities	4.95	5.26	4.65	1.92	0.98	0.35
Total Current Liabilities	63.77	53.33	30.83	16.43	10.79	7.88
Long-Term Debt	9.15	3.77	2.37	3.65	2.73	5.43
Long-Term Leases	6.83	6.27	5.74	5.34	0.88	1.21
Pension & Post-Retirement Benefits	4.8	3.85	2.84	1.89	1.4	1.19
Total Liabilities	84.56	67.22	41.77	27.31	15.79	15.7

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	54	54	36	36	30	30
Additional Paid-In Capital	7.24	7.24	11.52	11.52	-	-
Retained Earnings	5.07	2.99	13.73	1.25	16.96	11.47
Comprehensive Income & Other	0.85	0.9	-0.24	-	0.47	0.11
Shareholders' Equity	67.16	65.13	61	48.76	47.42	41.57
Total Liabilities & Equity	151.72	132.35	102.77	76.07	63.22	57.28

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	42.54	29.08	15.4	11.32	7.53	8.74
Net Cash (Debt)	-39.7	-24.54	-9.05	7.43	-4.23	-5.23
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.72	-0.45	-0.17	0.16	-0.09	-0.16
Filing Date Shares Outstanding	52.07	54	54	54	54	32.82
Total Common Shares Outstanding	52.07	54	54	54	45	32.82
Working Capital	39.81	31.02	26.8	33.41	34.04	34.58
Book Value Per Share	1.29	1.21	1.13	0.90	1.05	1.27
Tangible Book Value	67.04	64.99	60.83	48.56	47.42	41.57
Tangible Book Value Per Share	1.29	1.20	1.13	0.90	1.05	1.27
Buildings	-	10.59	10.59	1.95	1.95	1.95
Machinery	-	28.9	25.45	10.91	8.2	6.97
Construction In Progress	-	0.55	-	12.38	11.22	7.36
Leasehold Improvements	-	2.16	2	0.86	0.25	0.25

Data Source: S&P Global Market Intelligence Last updated: Sep 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error